Case Study: Global Biotech Company achieves 95% patient adherence with Axtria patient data analytics

Enabling 95% Patient Adherence With Rapid Patient Data Analytics

Global Biotech Company needed a better way to manage fragmented patient-level data and use protected health information to understand the full patient treatment journey, improve therapy adherence, and support better clinical and commercial decisions. Axtria addressed this challenge by helping the company bring complex data from across geographies into a unified analytics environment, using Axtria DataMax™ in a HIPAA-compliant setting.

Axtria implemented advanced patient analytics on top of the unified data hub to turn fragmented records into actionable insights. As a result, the Global Biotech Company achieved 95% patient adherence, improved health outcomes, and gained industry recognition, while reducing time to generate patient-journey insights from once every six months to weekly.